SAMSUNG BIOLOGICS CO.,LTD.
A CDMO providing end-to-end development and manufacturing services for the biopharma industry.
207940 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 송도바이오대로 300, 인천광역시
- Website:
- https://samsungbiologics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) providing end-to-end services to the global biopharmaceutical industry. The company offers a comprehensive service suite from late discovery, cell line and process development to large-scale, CGMP-compliant manufacturing of drug substance (DS) and drug product (DP). Its offerings also include analytical testing services and development support for new modalities such as antibody-drug conjugates (ADCs) and mRNA. Leveraging advanced infrastructure and a strong regulatory track record, Samsung Biologics supports its clients, which include many of the world's leading pharmaceutical companies, from clinical development through to commercial supply.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SAMSUNG BIOLOGICS CO.,LTD. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-11 00:00 |
Registration Form
[기재정정]증권신고서(분할)
|
Korean | 4.7 MB | |
| 2025-09-09 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 8.2 KB | |
| 2025-09-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | |
| 2025-09-05 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 16.8 KB | |
| 2025-09-02 00:00 |
Registration Form
[기재정정]증권신고서(분할)
|
Korean | 5.2 MB | |
| 2025-09-01 00:00 |
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 10.2 KB | |
| 2025-09-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | |
| 2025-09-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | |
| 2025-08-26 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
|
Korean | 7.7 KB | |
| 2025-08-25 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 37.5 KB | |
| 2025-08-22 00:00 |
M&A Activity
[기재정정]주요사항보고서(회사분할결정)
|
Korean | 56.1 KB | |
| 2025-08-22 00:00 |
Registration Form
증권신고서(분할)
|
Korean | 4.5 MB | |
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 4.5 MB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 5.0 MB |
Automate Your Workflow. Get a real-time feed of all SAMSUNG BIOLOGICS CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SAMSUNG BIOLOGICS CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
